Immediate Impact

56 standout
Sub-graph 1 of 24

Citing Papers

Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial
2024 Standout
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
2023 Standout
1 intermediate paper

Works of D Limido being referenced

Controlled Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous Nephropathy
1984

Author Peers

Author Last Decade Papers Cites
D Limido 344 174 51 73 13 405
Angelo Testa 322 111 52 77 14 453
D. S. Han 276 65 66 59 14 383
Richard W. Baehler 256 117 23 45 15 413
Irvin M. Cohen 188 109 25 83 16 441
Emilio Rivolta 288 71 28 100 10 408
Myra Chiang 197 86 59 36 12 386
Allan I. Jacob 168 73 19 98 13 396
G.B. Fogazzi 331 126 13 77 14 418
F Sarró 243 83 87 102 16 404
Marina Martic 108 71 30 70 10 355

All Works

Loading papers...

Rankless by CCL
2026